ArticleThe Pan African medical journal2025
Fatigue, cognitive complaints, dyspnea, anxiety, and depression as post-COVID syndrome: a cross-sectional study in Sfax, Southern Tunisia.
Article in The Pan African medical journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
17 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: post-COVID refers to symptoms and health problems that continue or develop after the initial phase of a COVID-19 infection has resolved. It represents a huge public health issue, leading to considerable illness and lowering the quality of life for those affected. Our study aimed first to provide a general description of post-COVID conditions and then to examine the specific aspects of fatigue, cognitive complaints, dyspnea, anxiety, and depression in patients followed up in the pulmonology department of CHU Hedi Chaker, Sfax. Methods: we conducted a cross-sectional study in the pulmonology department of CHU Hedi Chaker, Sfax in 2024 using an anonymous self-questionnaire with 4 validated scales to assess cognitive complaint, fatigue, dyspnea, as well as anxiety, and depression. Results: overall, 75 participants were included, with a sex ratio of 0.63 and a median age of 45 years (interquartile range (IQR= [35-66 years]). The evaluation of the impact of COVID-19 symptoms on daily life showed that 45.3% of the participants (n= 34) reported that fatigue had a severe impact on daily life, while 33.3% (n= 25) reported severe impacts from stress and negative emotions. The prevalences of fatigue, cognitive complaints, very severe dyspnea, anxiety, and depression based on the scale used were 88% (n= 66), 80% (n= 60), 14.7% (n= 11), 44% (n= 33) and 28.6% (n= 21), respectively. The factor most associated with fatigue in the population was cognitive complaints (OR= 25.3, p<0.001), while the factor most associated with dyspnea was age between 70 and 95 (OR= 12.85; p= 0.006). Furthermore, the factor most significantly associated with cognitive complaints was anxiety with an OR of 25.3 and p<0.001. As for anxiety and depression, the most associated factors were cognitive complaints and depression (OR=25.3; p<0.001) vs (OR= 27.1; p<0.001), respectively. Conclusion: our study shows significant prevalences of post-COVID symptoms, such as fatigue, cognitive complaints, severe dyspnea, anxiety, and depression. Thus, post-COVID syndrome poses a significant public health challenge due to its wide array of symptoms that continue to affect individuals' health.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.